MOUNJARO 2.5 MG

The origin of this product is Europe  product of europe

Quick Overview

Mounjaro, developed by Eli Lilly, is a once-weekly injectable treatment containing the active ingredient tirzepatide, designed to support weight loss. It works by helping you feel fuller for longer and reducing appetite, making it easier to manage food intake. Mounjaro is approved and licensed for weight loss in the UK and is available by prescription.

Availability: In stock

US $599.00
OR

MOUNJARO 2.5 MG

Double click on above image to view full picture

Zoom Out
Zoom In

More Views

Details

The pack includes:

 

  • • Each dose (0.6 ml) contains 2.5 mg of tirzepatide.

 

Mounjaro mimics hormones that naturally occur in the gut after eating, called incretins. Incretins have many functions, such as:

 

    • • slowing down the emptying of the stomach
    • • sending signals to your brain that you’re full after eating
    • • increasing insulin levels

 

 

These combined effects help people feel full after a meal by signalling to the parts of the brain responsible for appetite, making it easier to eat less.

 

 

 

THE ORIGIN OF THIS PRODUCT IS FROM THE EUROPEAN COMMUNITY (EC)

 

Additional Information

Manufacturer No
Brand No
Strength No
Pack Size No